Ad is loading...
HGHTX vs SHSAX
HGHTX vs SHSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
HGHTX vs. SHSAX commentary
Dec 19, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHTX is a Buy and SHSAX is a Buy.
FUNDAMENTALS
Fundamentals
SHSAX has more cash in the bank: 7.53B vs. HGHTX (952M). SHSAX pays higher dividends than HGHTX: SHSAX (0.23) vs HGHTX (0.00). HGHTX was incepted earlier than SHSAX: HGHTX (18 years) vs SHSAX (25 years). HGHTX is a more actively managed with annual turnover of: 32.00 vs. SHSAX (29.00). HGHTX has a lower initial minimum investment than SHSAX: HGHTX (0) vs SHSAX (1000). HGHTX annual gain was more profitable for investors over the last year : 0.46 vs. SHSAX (-0.50). HGHTX return over 5 years is better than : 0.37 vs. SHSAX (-0.07).
| HGHTX | SHSAX | HGHTX / SHSAX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 18 years | 25 years | - |
| Gain YTD | -1.989 | -2.401 | 83% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 952M | 7.53B | 13% |
| Annual Yield % from dividends | 0.00 | 0.23 | - |
| Returns for 1 year | 0.46 | -0.50 | -93% |
| Returns for 3 years | -8.50 | -12.74 | 67% |
| Returns for 5 years | 0.37 | -0.07 | -517% |
| Returns for 10 years | 9.11 | 28.69 | 32% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EDV | 71.85 | 0.51 | +0.71% |
| Vanguard Extended Duration Trs ETF | |||
| TPYP | 34.16 | -0.20 | -0.58% |
| Tortoise North American Pipeline | |||
| FJP | 51.06 | -0.35 | -0.68% |
| First Trust Japan AlphaDEX® ETF | |||
| FDCF | 39.10 | -0.30 | -0.77% |
| Fidelity Disruptive Communications ETF | |||
| CNCR | 12.66 | -0.15 | -1.20% |
| Range Cancer Therapeutics ETF | |||